Early research (Phase 1)Study completedNCT00098332
What this trial is testing
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
Who this might be right for
Lymphoma
BioCryst Pharmaceuticals